Abstract

In this issue of Blood, Ju and colleagues report that a selective inhibitor of Janus kinase 3 (Jak3) blocks autocrine and paracrine interleukin 2 (IL-2), IL-9, and IL-15 activation, which is important for lymphocyte proliferation induced by human T-cell leukemia virus (HTLV).1.

Original languageEnglish
Pages (from-to)1771-1772
Number of pages2
JournalBlood
Volume117
Issue number6
DOIs
StatePublished - Feb 10 2011

Fingerprint

Dive into the research topics of 'JAK blockade and HTLV'. Together they form a unique fingerprint.

Cite this